The hormone sensitive lymph node derived metastatic prostate cancer cell line LNCaPFGC were choose as the best proxy to study the possible impact of TRPM8 agonists on either enzalutamide or docetaxel efficacy. Here, TRPM8 is linked to metastatic prostate carcinoma.